Investor Presentaiton slide image

Investor Presentaiton

Clearly Articulated Capital Allocation Priorities Our Leading Portfolio Provides Significant Opportunity for Growth $3.7B 2021 Announced $1.4B Investment Activity Ongoing development principally Senior Housing in Life Science, R&I and Canadian senior housing markets 70% of $3.7B 819 Communities ~$1B Forward pipeline of Life Science, R&I projects 47% Annualized Adjusted NOI Historical Acquisition Volume A VENTASⓇ Life Science, R&I 20% of $3.7B 43 Centers + Medical Office 10% of $3.7B 309 Buildings 10% Annualized Adjusted NOI 22% Annualized Adjusted NOI Strong Track Record of External Investment Experienced investments team, broad relationships and processes with long track record of significant external growth $12.0 $10.0 $8.0 $6.0 $4.0 $2.0 $- 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 >$3B Annual Average 2011-2021 6000 2021 15
View entire presentation